Acetated Ringer's Solution Versus Saline in Patients With Septic Shock
NCT04507672 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2000
Last updated 2020-08-11
Summary
The primary aim of this trial is to compare the effect of acetated ringer's solution with that of saline for therapy on the incidence and development of major adverse renal events among septic shock patients. The investigators hypothesize that use of acetated ringer's solution for resuscitation among septic shock patients will reduce the incidence of major adverse kidney events.
Conditions
- Septic Shock Hyperdynamic
Interventions
- DRUG
-
Fluid resuscitation
Use the choice of crystalloid for resuscitation during the first 72 hours after enrollment
Sponsors & Collaborators
-
Southeast University, China
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-09-01
- Primary Completion
- 2023-10-01
- Completion
- 2023-12-01
More Related Trials
-
Methylene Blue in Early Septic Shock
NCT04446871 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Therapeutic Plasma Exchange in Adult Patients With Severe Sepsis
NCT04057872 ·Status: COMPLETED ·Phase: PHASE1
-
Australasian Resuscitation In Sepsis Evaluation: FLUid or Vasopressors In Emergency Department Sepsis
NCT04569942 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Vasculopathic Injury and Plasma as Endothelial Rescue in Septic Shock (SHOCK) Trial
NCT03092245 ·Status: COMPLETED ·Phase: PHASE2
-
Emergency Department Management of Sepsis Patients: A Goal-Oriented Non-Invasive Sepsis Trial
NCT01453270 ·Status: COMPLETED ·Phase: NA
-
The Randomized Controlled Trial of Inferior Vena Cava Ultrasound-guided Fluid Management in Septic Shock Resuscitation
NCT03020407 ·Status: COMPLETED ·Phase: NA
-
Hyperoxia and Hypertonic Saline in Septic Shock
NCT01722422 ·Status: TERMINATED ·Phase: NA
-
Vasculopathic Injury and Plasma as Endothelial Rescue in Septic Shock Trial. VIPER-Sepsis (EudraCT no. 2016-000707-81)
NCT02875236 ·Status: TERMINATED ·Phase: PHASE4
-
The Effects of Blood Pressure on Renal Function and Oxygenation in Septic Shock
NCT02453425 ·Status: COMPLETED ·Phase: NA
-
Fluid Resuscitation in Early Septic Shock
NCT00819416 ·Status: COMPLETED ·Phase: PHASE2
-
The Conservative vs. Liberal Approach to Fluid Therapy of Septic Shock in Intensive Care Trial
NCT03668236 ·Status: COMPLETED ·Phase: PHASE4
-
Survey of Non-resuscitation Fluids in Septic Shock
NCT03438097 ·Status: COMPLETED
-
The Effect of Increasing the Mean Arterial Pressure on the Microcirculation and the Prognosis of Patients With Septic Shock
NCT04136080 ·Status: UNKNOWN ·Phase: NA
-
Protocolized Reduction of Non-resuscitation Fluids vs Usual Care in Septic Shock Feasibility Trial
NCT05249088 ·Status: COMPLETED ·Phase: NA
-
Acetaminophen and Ascorbate in Sepsis: Targeted Therapy to Enhance Recovery
NCT04291508 ·Status: COMPLETED ·Phase: PHASE2
-
Protocol-driven Hemodynamic Support for Patients With Septic Shock
NCT00335907 ·Status: UNKNOWN ·Phase: NA
-
Resuscitation With Plasma in Surgical and Trauma Patients With Septic Shock
NCT03366220 ·Status: TERMINATED ·Phase: PHASE2
-
Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis
NCT03434028 ·Status: COMPLETED ·Phase: PHASE3
-
Relation Between Mean Arterial Pressure and Renal Resistive Index in the Early Phase of Septic Shock
NCT04281277 ·Status: COMPLETED ·Phase: NA
-
Assessment of Two Levels of Arterial Pressure on Survival in Patients With Septic Shock
NCT01149278 ·Status: COMPLETED ·Phase: NA
-
Renin-guided Hemodynamic Management in Patients With Shock
NCT05898126 ·Status: RECRUITING ·Phase: NA
-
Venoarterial PCO2 Difference /Arteriovenous O2 Content Difference Ratio as Goal of Early Septic Shock Therapy
NCT01877798 ·Status: UNKNOWN ·Phase: NA
-
Venous Lactate in Progression to Overt Septic Shock and Mortality in Non-elderly Sepsis Patients in Emergency Department
NCT01947127 ·Status: COMPLETED
-
Methylene Blue in Severe Sepsis and Septic Shock
NCT01797978 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy and Safety of Methylene Blue in the Treatment of Severe Septic Shock
NCT06481410 ·Status: RECRUITING ·Phase: NA